Showing posts from November, 2023Show all
Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability health-issue

Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability

Nitesh sinha November 30, 2023

https://ift.tt/Fv1VqcX Sanofi’s Consumer Healthcare Unit launches the Shared Care Collective, an advisory group working to advance sustainability …

Read more
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease health-issue

Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease

Nitesh sinha November 27, 2023

https://ift.tt/ms2h37D Dupixent ® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirm…

Read more
Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC) health-issue

Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC)

Nitesh sinha November 09, 2023

https://ift.tt/aoFfXNw   from Sanofi - Aventis Groupe https://ift.tt/nkCVeNr via IFTTT

Read more